Catalyst Pharmaceuticals
CPRX
#4159
Rank
โ‚น258.22 B
Marketcap
โ‚น2,101
Share price
-7.23%
Change (1 day)
4.94%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: โ‚น258.22 Billion

As of March 2026 Catalyst Pharmaceuticals has a market cap of โ‚น258.22 Billion. This makes Catalyst Pharmaceuticals the world's 4159th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น258.22 B-3.89%
2025โ‚น268.67 B22.3%
2024โ‚น219.68 B47.25%
2023โ‚น149.19 B-6.86%
2022โ‚น160.18 B208.65%
2021โ‚น51.89 B104.72%
2020โ‚น25.35 B-8.32%
2019โ‚น27.65 B100.47%
2018โ‚น13.79 B-46.09%
2017โ‚น25.58 B332.52%
2016โ‚น5.91 B-56.15%
2015โ‚น13.48 B3.68%
2014โ‚น13.01 B99.5%
2013โ‚น6.52 B561.04%
2012โ‚น0.98 B-41.47%
2011โ‚น1.68 B95.92%
2010โ‚น0.86 B63.17%
2009โ‚น0.52 B-56.65%
2008โ‚น1.21 B-28.28%
2007โ‚น1.69 B-36.65%
2006โ‚น2.67 B

End of Day market cap according to different sources

On Feb 28th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

โ‚น278.36 Billion
by Nasdaq info icon info icon
โ‚น258.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น54.496 T 21,004.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น14.310 T 5,441.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น18.432 T 7,038.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น159.86 B-38.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น74.73 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.079 T 318.05%๐Ÿ‡บ๐Ÿ‡ธ USA